Endo subsidiary Par Sterile Products has entered into an agreement with the US government to expand its sterile fill-finish manufacturing production capacity and capabilities at its Rochester, Michigan plant to support national pandemic preparation efforts. The government will fund approximately $90m of the program’s expected total cost of around $120m.
The agreement has been made following efforts from the Department of Defense to address vulnerabilities in critical product supply chains...





